Medtech (robotic surgery)

Medtech
Founded 2002
Headquarters France
Key people
 Bertin Nahum, Founder & President[1]
Website medtech.fr/en/home

Medtech is a robotic surgery company founded in 2002 by Bertin Nahum and based near Montpellier, France, in Castelnau-le-Lez (Hérault department, in southern France. Medtech designs, develops and markets robotic assistance for surgical procedures of the central nervous system. It went public in a November 2013 initial public offering on Euronext Paris. Its ticker symbol and flagship product is ROSA, a robotic surgical assistant designed for low-invasive brain surgery.

Its pre-IPO investors include Newfund, Soridec, and Midi Capital.[2]

History

The first surgical robot developed by Medtech, in partnership with the Montpellier Laboratory of Computer Science, Robotics and Microelectronics (LIRMM), BRIGIT™, was dedicated to knee surgery. In 2006, Zimmer, the world leader in orthopedic implants, bought BRIGIT™’s entire patent portfolio.

Medtech decided to reinvest those resources in the development of a new robotic-assisted technology. Medtech’s first ROSA™ robot, ROSA Brain, dedicated to neurosurgery, is then designed. Comparable to a "GPS" for the brain, the robot can be used for any type of cranial procedures requiring surgical planning with preoperative data, patient’s registration and precise positioning and handling of instruments.[3]

Pathologies covered by the use of ROSA™ Brain are among others epilepsy, Parkinson's disease, generalized dystonia, cavernoma, hydrocephalus.[4]

The ROSA™ Brain device is present in 23 hospitals across Europe, North America, Asia and the Middle East[5] and has been used in more than 1 100 surgical procedures.[6]

Since late 2011, Medtech has continued innovating, through a project dedicated to spine surgery, the minimally invasive spine surgery robotic assistant ROSA Spine. In November 2013, the Park Clinic (Clinipole Group, Castelnau-le-Lez, South of France) acquired the very first ROSA Spine system.[7] In July 2014, Medtech announced the CE Marking of its new product ROSA Spine, which allows its marketing in Europe.[8]

On November the 28th of 2013, Medtech was listed in the Paris market operated by Euronext (NYSE Euronext, compartment C).[9]

Prizes and Awards

Medtech was elected Frost & Sullivan’s European Company of the Year for surgical robotics in 2013.[10]

References

  1. ↑ Gagliardi, Julien (27 February 2014). "Bertin Nahum – Medtech : "La France est un lieu d'excellence pour la robotique chirurgicale"". Atlantico (in French). Retrieved 1 March 2014.
  2. ↑ "Investors". Medtech company website.
  3. ↑ Medtech’s official website : http://medtech.fr/en/rosa1
  4. ↑ Medtech’s official website : http://medtech.fr/en/variety-of-disease
  5. ↑ Medtech’s official website : http://medtech.fr/en/rosa-worldwide
  6. ↑ Article from the French journal Echos.fr (November 2013) : http://www.lesechos.fr/entreprises-secteurs/innovateurs/0203121063320-le-robot-chirurgical-de-medtech-va-conquerir-les-etats-unis-629589.php
  7. ↑ Medtech’s official website : http://medtech.fr/en/news#67
  8. ↑ Medtech’s official website : http://medtech.fr/en/medtech-obtient-le-marquage-ce-de-son-robot-rosa-spine1
  9. ↑ NYSE News Release (28 November 2013) : "Archived copy". Archived from the original on 2014-08-08. Retrieved 2014-07-30.
  10. ↑ Medtech’s official website : http://medtech.fr/en/vision-and-mission#4
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.